FR2480782A1 - Anticorps, clones pour la production de ces anticorps, procede pour produire ces anticorps et ces clones et procede de determination immunologique utilisant ces anticorps - Google Patents

Anticorps, clones pour la production de ces anticorps, procede pour produire ces anticorps et ces clones et procede de determination immunologique utilisant ces anticorps Download PDF

Info

Publication number
FR2480782A1
FR2480782A1 FR8107213A FR8107213A FR2480782A1 FR 2480782 A1 FR2480782 A1 FR 2480782A1 FR 8107213 A FR8107213 A FR 8107213A FR 8107213 A FR8107213 A FR 8107213A FR 2480782 A1 FR2480782 A1 FR 2480782A1
Authority
FR
France
Prior art keywords
antibody
dht
antigen
antibodies
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8107213A
Other languages
English (en)
French (fr)
Other versions
FR2480782B1 (enExample
Inventor
Toshiyuki Hamaoka
Kayoko Tateishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4844780A external-priority patent/JPS56145222A/ja
Priority claimed from JP17276180A external-priority patent/JPS5795919A/ja
Application filed by Individual filed Critical Individual
Publication of FR2480782A1 publication Critical patent/FR2480782A1/fr
Application granted granted Critical
Publication of FR2480782B1 publication Critical patent/FR2480782B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR8107213A 1980-04-11 1981-04-10 Anticorps, clones pour la production de ces anticorps, procede pour produire ces anticorps et ces clones et procede de determination immunologique utilisant ces anticorps Granted FR2480782A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4844780A JPS56145222A (en) 1980-04-28 1980-04-11 Improved antibody and its preparation
JP17276180A JPS5795919A (en) 1980-12-08 1980-12-08 Improved antibody and its preparation

Publications (2)

Publication Number Publication Date
FR2480782A1 true FR2480782A1 (fr) 1981-10-23
FR2480782B1 FR2480782B1 (enExample) 1984-06-01

Family

ID=26388721

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8107213A Granted FR2480782A1 (fr) 1980-04-11 1981-04-10 Anticorps, clones pour la production de ces anticorps, procede pour produire ces anticorps et ces clones et procede de determination immunologique utilisant ces anticorps

Country Status (4)

Country Link
DE (1) DE3114362C2 (enExample)
DK (1) DK158644C (enExample)
FR (1) FR2480782A1 (enExample)
GB (1) GB2075987B (enExample)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0091760A1 (en) * 1982-04-09 1983-10-19 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Anti immune complex antibody and preparation thereof
EP0193881A3 (en) * 1985-03-06 1988-11-09 Boehringer Mannheim Gmbh Method and reagent for the determination of a luteinizing hormone, as well as the appropriate monoclonal hormone
EP0193880A3 (de) * 1985-03-06 1988-11-17 Roche Diagnostics GmbH Verfahren und Reagenz zur Bestimmung des Follikel stimulierenden Hormons sowie hierzu geeignete monoklonale Antikörper
WO1992003738A1 (en) * 1990-08-23 1992-03-05 Enfer Technology Limited Hormone detection methods
EP0640690A1 (en) * 1993-08-25 1995-03-01 Eli Lilly And Company Monoclonal antibodies specific for 5-dihydrotestosterone

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468346A (en) * 1983-10-27 1984-08-28 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to porcine immunoglobulins
US4772551A (en) * 1985-12-26 1988-09-20 Neogen Corporation Method and test kit for detecting a trichothecene using novel monoclonal antibodies
AU590405B2 (en) * 1986-02-26 1989-11-02 University Of Melbourne, The Hla-b27 testing

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2379287A1 (fr) * 1977-02-03 1978-09-01 Katz David Agent immunosuppresseur et son procede de preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51101120A (en) * 1975-02-28 1976-09-07 Dai Ichi Kogyo Seiyaku Co Ltd Kogen oyobi kotainoseiho

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2379287A1 (fr) * 1977-02-03 1978-09-01 Katz David Agent immunosuppresseur et son procede de preparation

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 94, no. 3, 19 janvier 1981, page 164, résumé no. 12416u, COLUMBUS, Ohio (US) *
CHEMICAL ABSTRACTS, vol. 94, no. 3, 19 janvier 1981, page 164, résumé no. 12417v, COLUMBUS, Ohio (US) *
JOURNAL OF ENDOCRINOLOGY, vol. 87, no. 2, 1980 *
STEROIDS, vol. 28, no. 1, juillet 1976, pages 101-109 *
STEROIDS, vol. 36, no. 3, septembre 1980 *
THE JOURNAL OF IMMUNOLOGY, vol. 114, no. 2, Part 2, février 1975, pages 872-876, (US) *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0091760A1 (en) * 1982-04-09 1983-10-19 FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. Anti immune complex antibody and preparation thereof
EP0193881A3 (en) * 1985-03-06 1988-11-09 Boehringer Mannheim Gmbh Method and reagent for the determination of a luteinizing hormone, as well as the appropriate monoclonal hormone
EP0193880A3 (de) * 1985-03-06 1988-11-17 Roche Diagnostics GmbH Verfahren und Reagenz zur Bestimmung des Follikel stimulierenden Hormons sowie hierzu geeignete monoklonale Antikörper
WO1992003738A1 (en) * 1990-08-23 1992-03-05 Enfer Technology Limited Hormone detection methods
EP0640690A1 (en) * 1993-08-25 1995-03-01 Eli Lilly And Company Monoclonal antibodies specific for 5-dihydrotestosterone

Also Published As

Publication number Publication date
GB2075987A (en) 1981-11-25
DE3114362A1 (de) 1982-03-18
DK158644B (da) 1990-06-25
GB2075987B (en) 1983-06-02
DK158644C (da) 1990-11-19
FR2480782B1 (enExample) 1984-06-01
DE3114362C2 (de) 1983-08-18
DK164381A (da) 1981-10-12

Similar Documents

Publication Publication Date Title
US4722899A (en) Producing highly specific, low cross-reactive antibody by immunizing with copolymer of D-glutamic acid and lysine
US5026827A (en) Amphetamine-protein complex as immunogen for obtaining antibodies specific to methamphetamine
JPH0811075B2 (ja) 単クローン性抗ｃｅａ抗体
EP0548138A1 (en) Methods of treating, diagnosing and monitoring therapies from levels of human oubain-like factor and antibody thereof
US5233025A (en) Amphetamine protein complex as immunogen for obtaining antibodies specific to methamphetamine
CN107698653B (zh) 一种雷公藤甲素半抗原及其制备方法与应用
GB2098730A (en) Immunolocalisation
FR2480782A1 (fr) Anticorps, clones pour la production de ces anticorps, procede pour produire ces anticorps et ces clones et procede de determination immunologique utilisant ces anticorps
CN109824599A (zh) 一种阿苯达唑半抗原及其制备方法和应用
CN101066998B (zh) 甲羟孕酮醋酸酯特异性抗体的制备及该抗体用于同源或异源酶联免疫分析的方法
CN101407480A (zh) 氨基脲衍生物半抗原、抗原和抗体的制备方法
JP2517561B2 (ja) カテコ−ルエストロゲンのイムノアツセイキツド
WO2001018196A1 (fr) Procede de detection de mycotoxines de trichothecene et leur reactif
CN111269262A (zh) 丙溴磷半抗原、人工抗原和抗体及其制备方法和应用
CN101135683A (zh) 联苯菊酯抗原、抗体及其应用
Kobayashi et al. Production and characterization of group-specific monoclonal antibodies recognizing nonamidated, glycine-and taurine-amidated ursodeoxycholic acid 7-N-acetylglucosaminides
Kayoko et al. A novel immunization procedure for production of anti-testosterone and anti-5α-dihydrotestosterone antisera of low cross-reactivity
CN111943881A (zh) 溴虫腈半抗原、人工抗原和抗体及其制备方法和应用
EP0041019B1 (fr) Nouveaux produits préparés à partir du facteur thymique sérique ou de ses analogues et dérivés, procédé de préparation de ces produits, ces produits pour utilisation comme médicaments, traceurs obtenus à partir de ces produits et utilisation de ces traceurs dans des procédés de dosage
WO1993003365A1 (en) Immunoassay, monoclonal antibody and hybridoma
JPS62500421A (ja) モノクロ−ナル抗−イデイオタイプ抗体の産生方法
JPH0323151B2 (enExample)
JPH0158459B2 (enExample)
CN119874905B (zh) 一种夹心检测睾酮的单克隆抗体及其制备方法、应用
US20110207154A1 (en) Method for determination of marinobufagenin levels and compounds employable in such method

Legal Events

Date Code Title Description
ST Notification of lapse